Target intelligence / Profile preview

UBE2V1 pseudogene 16 (UBE2V1P16)

Target
UBE2V1P16
Molecular classification
Other (Pseudogene)
01

Overview

UBE2V1 pseudogene 16 is classified as a pseudogene and is not known to produce a protein product or possess biological activity. Pseudogenes such as UBE2V1P16 are nonfunctional DNA segments that are similar in sequence to functional genes—in this case, UBE2V1 (Ubiquitin-conjugating enzyme E2 variant 1)—but have lost their protein-coding potential through accumulated mutations or deletions[4]. There is no evidence that UBE2V1P16 is expressed or implicated in any normal or pathological processes. UBE2V1P16 is therefore not considered a druggable target, receptor, enzyme, or participant in any known molecular pathway, nor is it associated with any established disease risk, drug interaction, or biomarker signature[4]. Pseudogenes are generally annotated for the purpose of genomic mapping and evolutionary biology, but do not have known biological functions or therapeutic relevance. If a biologically active or druggable molecule is intended, review the gene symbol or search for the canonical UBE2V1 gene or protein[1][2][4].

Beyond the preview

Go deeper on UBE2V1 pseudogene 16 (UBE2V1P16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UBE2V1 pseudogene 16 (UBE2V1P16).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call